← All China Pharma Holdings, INC filings

China Pharma Holdings, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
CPHI
China Pharma Holdings, INC
DEF 14A: China Pharma Seeks Reverse Split to Avoid Delisting
China Pharma Holdings, Inc. will hold its Annual Meeting to vote on a reverse stock split, an independent director election, and an amendment to its long-term incentive plan.
AMEX
CPHI
China Pharma Holdings, INC
DEF 14A: China Pharma Holdings Seeks Stockholder Approval for Reverse Stock Split and Incentive Plan Amendment
China Pharma Holdings is asking stockholders to vote on key proposals at its upcoming annual meeting, including a reverse stock split to maintain NYSE American listing and an amendment to its long-term incentive plan.